Constellation Investments’s Gilead Sciences GILD Stock Holding History

Constellation Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$6.05M	Sell	65,825 -2,100	-3%	-$189K	1.11%	14
2015 Q4	$6.87M	Sell	67,925 -400	-0.6%	-$41.6K	1.29%	10
2015 Q3	$6.71M	Buy	68,325 +125	+0.2%	+$13.9K	1.39%	7
2015 Q2	$7.99M	Sell	68,200 -225	-0.3%	-$24.6K	1.52%	7
2015 Q1	$6.71M	Buy	68,425 +1,025	+2%	+$104K	1.28%	9
2014 Q4	$6.35M	Buy	67,400 +1,925	+3%	+$199K	1.29%	9
2014 Q3	$6.97M	Sell	65,475 -775	-1%	-$75.9K	1.55%	7
2014 Q2	$5.49M	Sell	66,250 -600	-0.9%	-$46.7K	1.27%	10
2014 Q1	$4.74M	Buy	66,850 +3,250	+5%	+$255K	1.15%	14
2013 Q4	$4.78M	Buy	63,600 +4,375	+7%	+$305K	1.22%	12
2013 Q3	$3.72M	Buy	59,225 +3,925	+7%	+$235K	1.14%	14
2013 Q2	$2.83M	Buy	+55,300	New	+$2.88M	0.98%	22

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Constellation Investments's GILD Position: Q1 2016 in Review

Constellation Investments reduced its Gilead Sciences (GILD) stake by 3.1% in Q1 2016, selling an estimated $189K and leaving 65,825 shares worth $6.05M. The position accounts for 1.11% of the portfolio, ranked #14.

Constellation Investments first reported a position in GILD in Q2 2013 and has held it in 12 quarters since. The position peaked at $7.99M in Q2 2015. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Constellation Investments held 65,825 shares of Gilead Sciences worth $6.05M as of Q1 2016.
Constellation Investments sold 2,100 Gilead Sciences shares in Q1 2016, an estimated $189K.
Gilead Sciences made up 1.11% of Constellation Investments's portfolio in Q1 2016, its #14 holding.
Constellation Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 12 quarters since.
Constellation Investments's Gilead Sciences position peaked at $7.99M in Q2 2015.
1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.